Publicacions - IR Sant Pau

Cercar

01/09/2024 EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions

Ständer, S, Pereira, MP, Zeidler, C, Legat, FJ, Misery, L, Loenndahl, L, Bewley, AP, Brenaut, E, Bobko, S, Elberling, J, Evers, AWM, Garcovich, S, Gieler, U, Goncalo, M, Kupfer, J, Lambert, J, Lvov, A, Metz, M, Michenko, A, Papadavid, E, Reich, A, Savk, E, Schneider, G, Schut, C, Serra-Baldrich, E, Ständer, HF, Szepietowski, JC, Wallengren, J, Weisshaar, E, Augustin, M. EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2024; 38(9)DOI:10.1111/jdv.20102. PMID:38738586. IF:8.000(Q1/1D).

08/08/2024 Efficacy comparison of targeted systemic monotherapies including lebrikizumab for moderate-to-severe atopic dermatitis: a network meta-analysis

Silverberg, JI, Bieber, T, Paller, A, Beck, LA, Kamata, M, Puig, L, Wiseman, M, Ezzedine, K, Foley, P, Johansson, E, Dossenbach, M, Akmaz, B, Casillas, M, Karlsson, A, Chovatiya, R. Efficacy comparison of targeted systemic monotherapies including lebrikizumab for moderate-to-severe atopic dermatitis: a network meta-analysis. BRITISH JOURNAL OF DERMATOLOGY. 2024; 191DOI:10.1093/bjd/ljae266.014. PMID:. IF:9.600(Q1/1D).

03/08/2024 Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, trials

Bissonnette, R, Warren, RB, Pinter, A, Agner, T, Gooderham, M, Schuttelaar, MLA, Crépy, MN, Stingeni, L, Serra-Baldrich, E, Baranowski, K, Korn, S, Kurvits, M, Plohberger, U, Vest, NS, Schliemann, S. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, trials. LANCET. 2024; 404(10451)DOI:10.1016/S0140-6736(24)01027-4. PMID:39033766. IF:88.500(Q1/1D).

01/08/2024 Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search

Puig, L, Fujita, H, Thaçi, D, Zheng, M, Daly, ACH, Leonardi, C, Lebwohl, MG, Barker, J. Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search. Dermatology and Therapy. 2024; 14(9)DOI:10.1007/s13555-024-01230-z. PMID:39088126. IF:4.200(Q1/1D).

01/08/2024 Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice

Butrón-Bris, B, Llamas-Velasco, M, Ovejero-Benito, MC, Santos-Juanes, J, Martínez-López, A, Ruiz-Villaverde, R, Roustan, G, Baniandrés, O, Izu-Belloso, R, de la Cueva, P, Sahuquillo-Torralba, A, Gónzalez-Quesada, A, Vilarrasa-Rull, E, Pujol-Montcusi, J, García-Martínez, J, Navares, M, Palomar-Moreno, I, Novalbos, J, Abad-Santos, F, Daudén, E, de la Fuente, H. Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice. EXPERIMENTAL DERMATOLOGY. 2024; 33(8)DOI:10.1111/exd.15152. PMID:39081053. IF:3.100(Q2/3D).

01/08/2024 A Narrative Review of the IL-18 and IL-37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets

Rusinol, L, Puig, L. A Narrative Review of the IL-18 and IL-37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(15)DOI:10.3390/ijms25158437. PMID:39126010. IF:4.900(Q1/3D).

01/08/2024 Lentigo maligna: a comprehensive review on diagnosis and treatment

Carmona-Rocha, E, Rusiñol, L, Garcia-Melendo, C, Iznardo, H, Mozos, A, López-Sánchez, C, Yélamos, O. Lentigo maligna: a comprehensive review on diagnosis and treatment. Italian Journal of Dermatology and Venereology. 2024; 159(4)DOI:10.23736/S2784-8671.24.07837-X. PMID:39069838. IF:2.600(Q2/4D).

17/07/2024 International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council

Choon, SE, van de Kerkhof, P, Gudjonsson, JE, de la Cruz, C, Barker, J, Morita, A, Romiti, R, Affandi, AM, Asawanonda, P, Burden, AD, Gonzalez, C, Marrakchi, S, Mowla, MR, Okubo, Y, Oon, HH, Terui, T, Tsai, TF, Callis-Duffin, K, Fujita, H, Jo, SJ, Merola, J, Mrowietz, U, PUIG SANZ, LUIS, Thaçi, D, Velásquez, M, Augustine, M, El Sayed, M, Navarini, AA, Pink, A, Prinz, J, Turki, H, Magalhaes, R, Capon, F, Bachelez, H. International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council. JAMA Dermatology. 2024; DOI:10.1001/jamadermatol.2024.0915. PMID:38691347. IF:11.000(Q1/1D).

01/07/2024 Recommendations from the Spanish Academy of Dermatology and Venereology Psoriasis Working Group on the Management of Patients with Cancer and Psoriasis

Puig, L, Notario, J, López-Ferrer, A, Scheneller-Pavelescu, L, Pérez, B, Galache, C, de la Cueva, P, Carrascosa, JM. Recommendations from the Spanish Academy of Dermatology and Venereology Psoriasis Working Group on the Management of Patients with Cancer and Psoriasis. Actas Dermo-Sifiliograficas. 2024; 115(7)DOI:10.1016/j.ad.2024.02.013. PMID:38382743. IF:(Q/D).

01/07/2024 Validation of the Spanish Version of the PURE-4 Questionnaire for the Early Detection of Psoriatic Arthritis in Psoriatic Patients

Belinchón-Romero, I, López-Ferrer, A, Farrés, MFI, Rivera-Díaz, R, Vidal-Sarro, D, Fernández-Freire, LR, de la Cueva-dobao, P, Santos-Juanes, J, Rocamora-Durán, V, Martín-Vázquez, V, Gómez-Labradror, L, Queiro-Silva, R. Validation of the Spanish Version of the PURE-4 Questionnaire for the Early Detection of Psoriatic Arthritis in Psoriatic Patients. Actas Dermo-Sifiliograficas. 2024; 115(7)DOI:10.1016/j.ad.2024.05.010. PMID:38815678. IF:(Q/D).

01/07/2024 Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)

Navarro-Triviño, FJ, Borrego, L, Silvestre-Salvador, JF, Mercader-García, P, Giménez-Arnau, AM, Frutos, FJOD, Sanz-Sánchez, T, Melé-Ninot, G, Sánchez-Gilo, A, Zaragoza-Ninet, V, Serra-Baldrich, E, Miquel-Miquel, J, Córdoba-Guijarro, S, Rodríguez-Serna, M, Ruíz-González, I, Carrascosa-Carrillo, JM, de la Fuente, EG, Pastor-Nieto, MA, Heras-Mendaza, F, González-Pérez, R, Guillén, PSP, Sánchez-Pérez, J, Gatica-Ortega, ME, Fernández-Redondo, V, Hervella-Garcés, M, Manrique-Martínez, P, Guimaraens-Juanena, D, García-Gavín, J, Giménez-Arnau, E, Figueras-Nart, I, Curto-Barredo, L, Armario-Hita, JC. Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC). Actas Dermo-Sifiliograficas. 2024; 115(7)DOI:10.1016/j.ad.2024.03.024. PMID:38556197. IF:(Q/D).

01/07/2024 Epicensus: The Drive to Elevating the Standard of Care for Patients with Psoriasis

Thomsen, SF, Corazza, V, Augustin, M, Lazaridou, E, Puig, L, Guillevin, L. Epicensus: The Drive to Elevating the Standard of Care for Patients with Psoriasis. Dermatology and Therapy. 2024; 14(7)DOI:10.1007/s13555-024-01192-2. PMID:38896383. IF:4.200(Q1/1D).

01/07/2024 Information and consensus document for the diagnostic and therapeutic management of pruritus associated with chronic kidney disease in patients on haemodialysis in Spain

Buades, JM, Figueras-Nart, I, Goicoechea, M, Villanueva, RJS, Serra-Baldrich, E. Information and consensus document for the diagnostic and therapeutic management of pruritus associated with chronic kidney disease in patients on haemodialysis in Spain. NEFROLOGIA. 2024; 44(4)DOI:10.1016/j.nefro.2023.04.006. PMID:39034226. IF:2.600(Q2/4D).

21/06/2024 Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24-week multicenter study

Armario-Hita, JC, Pereyra-Rodriguez, JJ, González-Quesada, A, Herranz, P, Suarez, R, Galan-Gutiérrez, M, Rodríguez-Serna, M, de Frutos, JO, Carrascosa, JM, Serra-Baldrich, E, Ara-Martin, M, Figueras-Nart, I, Silvestre, JF, Zaragoza-Ninet, V, Ruiz-Villaverde, R. Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24-week multicenter study. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2024; 63(11)DOI:10.1111/ijd.17344. PMID:39425593. IF:3.200(Q1/3D).

19/06/2024 Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study

Mansilla-Polo, M, Pons-Benavent, M, Fernandez-Crehuet, P, Vilarrasa, E, Albanell-Fernandez, C, Morales-Tedone, E, Rausell-Felix, F, Alcala-Garcia, R, Matellanes-Palacios, M, Martin-Ezquerra, G, Alfageme, F, Ciudad-Blanco, C, Lopez-Villaescusa, MT, Garbayo-Salmons, P, Martorell, A, Escutia-Munoz, B, Navarro-Blanco, F, Martin-Torregrosa, D, Cuenca-Barrales, C, Molina-Leyva, A, Botella-Estrada, R. Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2024; 65(7)DOI:10.1111/ajd.14339. PMID:38895808. IF:1.800(Q3/6D).

11/06/2024 Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study

Chiricozzi, A, Coscarella, G, Puig, L, Vender, R, Yeung, JS, Carrascosa, JM, Piaserico, S, Gisondi, P, Lynde, C, Ferreira, P, Bastos, PM, Dauden, E, Leite, L, Valerio, J, del Alcazar-Viladomiu, E, Vilarrasa, E, Llamas-Velasco, M, Alessandri-Bonetti, M, Messina, F, Bruni, M, Di Brizzi, EV, Ricceri, F, Nidegger, A, Hugo, J, Mufti, A, Daponte, AI, Teixeira, L, Balato, A, Romanelli, M, Prignano, F, Gkalpakiotis, S, Conrad, C, Lazaridou, E, Rompoti, N, Stratigos, AJ, Nogueira, M, Peris, K, Torres, T. Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2024; 38(11)DOI:10.1111/jdv.20143. PMID:38860729. IF:8.000(Q1/1D).

10/06/2024 Periungual pyogenic granulomas after ravulizumab therapy in a child with acute myelomonocytic leukemia treated with hematopoietic stem cell transplant

Iznardo, H, López-Torija, I, Mateu-Arrom, L, Escribano-Sanz, P, Puig, L, Roé, E. Periungual pyogenic granulomas after ravulizumab therapy in a child with acute myelomonocytic leukemia treated with hematopoietic stem cell transplant. PEDIATRIC DERMATOLOGY. 2024; 41(5)DOI:10.1111/pde.15675. PMID:38858093. IF:1.200(Q3/7D).

01/06/2024 Duration of smoking cessation in patients with inflammatory bowel disease

González-Muñoza, C, Gely, C, Gordillo, J, Bertoletti, F, Giordano, A, Lopez-Faba, A, García-Planella, E. Duration of smoking cessation in patients with inflammatory bowel disease. Gastroenterologia y Hepatologia. 2024; 47(6)DOI:10.1016/j.gastrohep.2023.11.002. PMID:37977427. IF:1.900(Q3/7D).

01/06/2024 Italian S3-Guideline on the treatment ofAtopic Eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA)

Argenziano, G, Cusano, F, Corazza, M, Amato, S, Amerio, P, Naldi, L, Patruno, C, Pigatto, PD, Quaglino, P, Gisondi, P, Chiricozzi, A, Tonon, F, Stingeni, L, Calzavara-Pinton, P, Wollenberg, A, Kinberger, M, Arents, BW, Aszodi, N, Valle, GLA, Barbarot, S, Bieber, T, Brough, HA, Christen-Zäch, S, Deleuran, M, Dittmann, M, Dressler, C, Fink-Wagner, AH, Fosse, N, Gáspár, K, Gerbens, LA, Gieler, U, Girolomoni, G, Gregoriou, S, Mortz, CG, Nast, A, Nygaard, U, Redding, M, Rehbinder, EM, Ring, J, Rossi, M, Serra-Baldrich, E, Simon, D, Szalai, ZZ, Szepietowski, JC, Torrelo, A, Werfel, T, Flohr, C. Italian S3-Guideline on the treatment ofAtopic Eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA). Italian Journal of Dermatology and Venereology. 2024; 159(3)DOI:10.23736/S2784-8671.24.07667-9. PMID:38727635. IF:2.600(Q2/4D).

01/06/2024 Italian S3-Guideline on the treatment ofAtopic EczemaPart 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society ofAllergological and Environmental Dermatology (SIDAPA)

Argenziano, G, Cusano, F, Corazza, M, Amato, S, Amerio, P, Naldi, L, Patruno, C, Pigatto, PD, Quaglino, P, Gisondi, P, Chiricozzi, A, Tonon, F, Stingeni, L, Calzavara-Pinton, P, Wollenberg, A, Kinberger, M, Arents, BW, Aszodi, N, Avila Valle, GL, Barbarot, S, Bieber, T, Brough, H, Christen-Zäch, S, Deleuran, M, Dittmann, M, Dressler, C, Fink-Wagner, AH, Fosse, N, Gáspár, K, Gerbens, LA, Gieler, U, Girolomoni, G, Gregoriou, S, Mortz, CG, Nast, A, Nygaard, U, Redding, M, Rehbinder, EM, Ring, J, Rossi, M, Serra-Baldrich, E, Simon, D, Szalai, ZZ, Szepietowski, JC, Torrelo, A, Werfel, T, Flohr, C. Italian S3-Guideline on the treatment ofAtopic EczemaPart 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society ofAllergological and Environmental Dermatology (SIDAPA). Italian Journal of Dermatology and Venereology. 2024; 159(3)DOI:10.23736/S2784-8671.24.07664-3. PMID:38727633. IF:2.600(Q2/4D).

01/06/2024 [Translated article] Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC)

Verdaguer-Faja, J, Borrego, L, Mercader-García, P, Pérez, RG, Córdoba-Guijarro, S, Giménez-Arnau, AM, Ruiz-González, I, Miquel-Miquel, J, Silvestre, JF, de Frutos, FJO, Tous-Romero, F, Sánchez, TS, Rodríguez-Serna, M, Sánchez-Pérez, J, Baldrich, ES, Zaragoza-Ninet, V, Pastor-Nieto, MA, Gática-Ortega, ME, Gilo, AS, Melé-Ninot, G, Guillén, PSP, Munera-Campos, M, Descalzo, MA, García-Doval, I, Carrascosa, JM. [Translated article] Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC). Actas Dermo-Sifiliograficas. 2024; 115(6)DOI:10.1016/j.ad.2024.04.013. PMID:38648935. IF:(Q/D).

01/06/2024 Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC)

Verdaguer-Faja, J, Borrego, L, Mercader-García, P, Pérez, RG, Córdoba-Guijarro, S, Giménez-Arnau, AM, Ruiz-González, I, Miquel-Miquel, J, Silvestre, JF, de Frutos, FJO, Tous-Romero, F, Sánchez, TS, Rodríguez-Serna, M, Sánchez-Pérez, J, Baldrich, ES, Zaragoza-Ninet, V, Pastor-Nieto, MA, Gática-Ortega, ME, Gilo, AS, Melé-Ninot, G, Guillén, PSP, Munera-Campos, M, Descalzo, MA, Garcia-Doval, I, Carrascosa, JM. Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC). Actas Dermo-Sifiliograficas. 2024; 115(6)DOI:10.1016/j.ad.2024.02.009. PMID:38382750. IF:(Q/D).

01/06/2024 The prevalence of skin diseases in Greece, impact on quality of life and stigmatization: A population-based survey study

Stratigos, AJ, Richard, MA, Dessinioti, C, Paul, C, Nijsten, T, Gisondi, P, Salavastru, C, Taieb, C, Trakatelli, M, Puig, L, Tzellos, T, Ioannides, D. The prevalence of skin diseases in Greece, impact on quality of life and stigmatization: A population-based survey study. Jeadv Clinical Practice. 2024; 3(2)DOI:10.1002/jvc2.287. PMID:. IF:(Q/D).

01/06/2024 The surface antigens of circulating small extracellular vesicles, as non-invasive markers of the immune mechanisms involved in liver diseases according to etiology

Guinart-Cuadra, A, Brujats, A, de la Torre, M, Osuna-Gómez, R, Cantó, E, Poca, M, Roman, E, Fajardo, J, Santamaria, E, Soriano, G, Villanueva, C, Escorsell, A, Gely, C, Argemi, JM, D'Avola, D, Vidal, S, Alvarado-Tapias, E. The surface antigens of circulating small extracellular vesicles, as non-invasive markers of the immune mechanisms involved in liver diseases according to etiology. JOURNAL OF HEPATOLOGY. 2024; 80DOI:. PMID:. IF:33.000(Q1/1D).

14/05/2024 The "Burden of Skin Diseases" Project: a population-based study on 44,689 participants from 27 European countries

Paul, C, Stratigos, AJ, Nijsten, T, Gisondi, P, Salavastru, C, Röecken, M, Taieb, C, Sampogna, F, Trakatelli, M, Puig, L, Richard, MA. The "Burden of Skin Diseases" Project: a population-based study on 44,689 participants from 27 European countries. MINERVA MEDICA. 2024; DOI:10.23736/S0026-4806.24.09262-0. PMID:38743041. IF:4.700(Q/D).

12/05/2024 Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group

Sahuquillo-Torralba, A, Mansilla-Polo, M, Pujol-Marco, C, Llamas-Velasco, M, Rull, EV, Villaverde, RR, Ferran, M, Pitarch, G, Lopez, A, Beltran, E, Urruticoechea-Arana, A, Riera-Monroig, J, Alsina, M, Vidal, D, Romero, IB, Notario, J, Carrascosa, JM, Gonzalez-Delgado, V, Mollet, J, Ribera, M, Gallardo, F. Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2024; 63(12)DOI:10.1111/ijd.17238. PMID:38736107. IF:3.200(Q1/3D).

01/05/2024 Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish Dermatologists

Vilarrasa, E, Rivera, R, Eiris, N, Carretero, G, de la Cueva, P, Carrascosa, JM. Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish Dermatologists. Actas Dermo-Sifiliograficas. 2024; 115(5)DOI:10.1016/j.ad.2023.10.022. PMID:37925068. IF:(Q/D).

01/05/2024 Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study

Pinter, A, Soliman, AM, Pivneva, I, Ghanbariamin, R, Yang, M, Truong, B, Puig, L, Lebwohl, M. Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study. Dermatology and Therapy. 2024; 14(5)DOI:10.1007/s13555-024-01164-6. PMID:38727996. IF:4.200(Q1/1D).

01/05/2024 Dose escalation of biologic treatment in patients with moderate-to-severe psoriasis in Japan

Tada, Y, Soliman, AM, Ishii, K, Sakuma, R, Pinter, A, Davis, M, Nunag, D, Buessing, M, Puig, L, Imafuku, S. Dose escalation of biologic treatment in patients with moderate-to-severe psoriasis in Japan. EXPERIMENTAL DERMATOLOGY. 2024; 33(5)DOI:10.1111/exd.15067. PMID:38757460. IF:3.100(Q2/3D).

01/05/2024 2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?

Gatica-Ortega, ME, Pastor-Nieto, MA, Giménez-Arnau, AM, Mercader-García, P, Sanz-Sánchez, T, Carrascosa-Carrillo, JM, Córdoba-Guijarro, S, Sánchez-Pérez, J, Silvestre, JF, Frutos, FJOD, Tous-Romero, F, Fernández-Redondo, V, Serra-Baldrich, E, Ruíz-González, I, Pérez, RG, Miquel-Miquel, J, Guillén, PSP, Hervella-García, M, Heras-Mendaza, F, Gómez-de-la-Fuente, E, Zaragoza-Ninet, V, Gilo, AS, Rodríguez-Serna, M, Melé-Ninot, G, Descalzo, MA, de-Vega, M, García-Doval, I, Borrego, L. 2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?. CONTACT DERMATITIS. 2024; 90(5)DOI:10.1111/cod.14520. PMID:38351475. IF:4.600(Q1/1D).

24/04/2024 An integrated safety analysis of treatment-emergent fungal infections in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis treated with ixekizumab from 26 clinical studies

Schwartzman, S, Puig, L, Cohen, AD, Khattri, S, Jossart, C, Diaz, C, Garrelts, A, Zhu, DT, Eberhart, N, Eleftheriadi, A, Tangsirisap, N, Schuster, C, Gottlieb, AB, Sheesh, M. An integrated safety analysis of treatment-emergent fungal infections in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis treated with ixekizumab from 26 clinical studies. RHEUMATOLOGY. 2024; 63DOI:10.1093/rheumatology/keae163.211. PMID:. IF:4.400(Q1/1D).

01/04/2024 Prominent Skin Markings on the Dermoscopic Evaluation of Melanocytic Lesions: The Importance of Context

Mateu-Arrom, L, López-Sánchez, C, Yélamos, O. Prominent Skin Markings on the Dermoscopic Evaluation of Melanocytic Lesions: The Importance of Context. Dermatology Practical & Conceptual. 2024; 14(2)DOI:10.5826/dpc.1402a126. PMID:38810050. IF:2.300(Q2/5D).

01/04/2024 "Tracing the origins of setons in hidradenitis suppurativa: A commentary to Vilarrasa et al's 'Drainage setons for the management of sinus tracts in hidradenitis suppurativa Response

Camiña-Conforto, G, Vilarrasa, E, Cabo, F, Fernández-Vela, J, Pousa, M, Romaní, J. "Tracing the origins of setons in hidradenitis suppurativa: A commentary to Vilarrasa et al's 'Drainage setons for the management of sinus tracts in hidradenitis suppurativa Response. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2024; 90(4)DOI:10.1016/j.jaad.2023.11.049. PMID:38056528. IF:11.800(Q1/1D).

01/04/2024 Management of hidradenitis suppurativa tunnels using drainage setons: A retrospective multicentric study

Fernández-Vela, J, Romaní, J, Cabo, F, Pousa, M, Camiña, G, Guilabert, A, Vilarrasa, E. Management of hidradenitis suppurativa tunnels using drainage setons: A retrospective multicentric study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2024; 90(4)DOI:10.1016/j.jaad.2023.12.033. PMID:38160809. IF:11.800(Q1/1D).

01/04/2024 Four-year Epidemiological Surveillance of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy: Current Situation and Trends

Tous-Romero, F, Borrego-Hernando, L, García-Doval, I, Mercader-García, P, Silvester-Salvador, JF, Sánchez-Gilo, A, Sanz-Sánchez, T, Gimenéz-Arnau, AM, Zaragoza-Ninet, V, Miquel-Miquel, J, Pérez, RG, Cordoba-Guijarro, S, Carrascosa-Carrillo, JM, Gática-Ortega, ME, Ruíz-González, I, Serra-Baldrich, E, Pastor-Nieto, A, Rodríguez-Serna, M, Sánchez-Pérez, J, Ninot, GM, Guillén, PSP, Frutos, JOD. Four-year Epidemiological Surveillance of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy: Current Situation and Trends. Actas Dermo-Sifiliograficas. 2024; 115(4)DOI:10.1016/j.ad.2024.02.006. PMID:. IF:(Q/D).

26/03/2024 Treatment of extramammary Paget disease with imiquimod in a real-life setting: a multicentre retrospective analysis in Spain

Escolá, H, Llombart, B, Escolá-Rodríguez, A, Barchino-Ortiz, L, Marcoval, J, Alcaraz, I, Beá-Ardébol, S, Toll, A, Miñano-Medrano, R, Rodríguez-Jiménez, P, López-Nuñez, M, Ferrándiz-Pulido, C, Jaka, A, Masferrer, E, Aguayo-Ortiz, RS, Yébenes, M, Arandes-Marcocci, J, Ruiz-Salas, V, Turrión-Merino, L, Just, M, Sánchez-Schmidt, J, Leal, L, Mayo-Martínez, F, Haya-Martínez, L, Sandoval-Clavijo, A, Dradi, GG, Delgado, Y, Verdaguer-Faja, J, López-Castillo, D, Pujol, RM, Deza, G. Treatment of extramammary Paget disease with imiquimod in a real-life setting: a multicentre retrospective analysis in Spain. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2024; 49(10)DOI:10.1093/ced/llae092. PMID:38531692. IF:2.800(Q2/4D).

01/03/2024 Assessment of potential predictive factors of dupilumab response in patients with moderate-to-severe atopic dermatitis

Melé-Ninot, G, Curto-Barredo, L, Bonfill-Orti, M, Expósito-Serrano, V, Munera-Campos, M, Nart, IF, Loughlin, CRM, Gómez-Armayones, S, Spertino, J, Serra-Baldrich, E. Assessment of potential predictive factors of dupilumab response in patients with moderate-to-severe atopic dermatitis. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2024; 65(2)DOI:10.1111/ajd.14196. PMID:38058123. IF:1.800(Q3/6D).

01/03/2024 Comparative Treatment of Mucocutaneous Lesions in Hereditary Haemorrhagic Telangiectasia Patients With Dual Sequential Pulsed Dye Laser and Neodymium: Yttrium-Aluminium-Garnet Versus Neodymium: Yttrium-Aluminium-Garnet Laser Alone: A Double-Blind Randomized Controlled Study With Quality-of-Life Evaluation

Cubiro, X, Garcia-Melendo, C, Morales-Munera, CE, Riera-Mestre, A, Torres-Iglesias, R, Villanueva, B, Puig, L, Baselga, E. Comparative Treatment of Mucocutaneous Lesions in Hereditary Haemorrhagic Telangiectasia Patients With Dual Sequential Pulsed Dye Laser and Neodymium: Yttrium-Aluminium-Garnet Versus Neodymium: Yttrium-Aluminium-Garnet Laser Alone: A Double-Blind Randomized Controlled Study With Quality-of-Life Evaluation. Actas Dermo-Sifiliograficas. 2024; 115(3)DOI:10.1016/j.ad.2024.01.003. PMID:38185205. IF:(Q/D).

01/03/2024 Reflectance Confocal Microscopy Terminology in Spanish: A Delphi Consensus Study

Abarzua-Araya, A, Bañuls, J, Cabo, H, Carrera, C, Gamo, R, González, S, Jaimes, N, Navarrete-Dechent, C, Anker, JP, Roldán-Marín, R, Segura, S, Yelamos, O, Puig, S, Malvehy, J. Reflectance Confocal Microscopy Terminology in Spanish: A Delphi Consensus Study. Actas Dermo-Sifiliograficas. 2024; 115(3)DOI:10.1016/j.ad.2024.01.018. PMID:38244840. IF:(Q/D).

01/03/2024 Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis

Silvestre, JF, Tribó, MJ, Armario-Hita, JC, Calleja-Hernández, MA, Ortiz-Frutos, FJ, Poveda, JL, Shepherd, J, Serra-Baldrich, E. Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis. Jeadv Clinical Practice. 2024; 3(1)DOI:10.1002/jvc2.275. PMID:. IF:(Q/D).

01/03/2024 Unmet clinical needs, burden of disease and treatment patterns in hidradenitis suppurativa: Real-world experience from Spain

Vilarrasa, E, Molina-Leyva, A, Martín, V, Coak, E, Truman, I, Wallinger, H, Richardson, C, Martorell, A. Unmet clinical needs, burden of disease and treatment patterns in hidradenitis suppurativa: Real-world experience from Spain. Jeadv Clinical Practice. 2024; 3(1)DOI:10.1002/jvc2.237. PMID:. IF:(Q/D).

01/01/2024 [Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases

Vilarrasa, E, Nicolau, J, de la Cueva, P, Goday, A, Gallardo, F, Martorell-Calatayud, A, Carrascosa, JM. [Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases. Actas Dermo-Sifiliograficas. 2024; 115(1)DOI:10.1016/j.ad.2023.10.019. PMID:37918631. IF:(Q/D).

01/01/2024 Predictors of Local Invasion in Infiltrative Basal Cell Carcinoma: Tumour Budding Outperforms the WHO Subtyping

Fernández-figueras, MT, Pérez-muñoz, N, Puig, L, Posada-caez, R, Victoria, RB, Henriquez, M, Musulen, E. Predictors of Local Invasion in Infiltrative Basal Cell Carcinoma: Tumour Budding Outperforms the WHO Subtyping. ACTA DERMATO-VENEREOLOGICA. 2024; 104DOI:10.2340/actadv.v104.40172. PMID:38956962. IF:3.700(Q1/2D).

01/01/2024 SAFETY IN PATIENTS WITH LATENT TUBERCULOSIS WHO RECEIVED CONCOMITANT ANTITUBERCULOSIS MEDICATIONS: ANALYSIS OF 11 STUDIES OF GUSELKUMAB IN PSORIATIC DISEASE

Puig, L, Tsai, TF, Soriano, ER, Bhutani, T, Miller, M, Kollmeier, AP, Li, S, You, Y, Li, HW, Patel, H, Lavie, F, Gooderham, M, Londoño, A, Lebwohl, M, Nash, P. SAFETY IN PATIENTS WITH LATENT TUBERCULOSIS WHO RECEIVED CONCOMITANT ANTITUBERCULOSIS MEDICATIONS: ANALYSIS OF 11 STUDIES OF GUSELKUMAB IN PSORIATIC DISEASE. ACTA DERMATO-VENEREOLOGICA. 2024; 104DOI:. PMID:. IF:3.700(Q1/2D).

10/11/2025 An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer

Balado-Simo, P, Morgado-Carrasco, D, Gomez-Armayones, S, Lopez-Ferrer, A, Barco, D, Ferrándiz-Pulido, C, Podlipnik, S. An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer. Journal of Clinical Medicine. 2025; 14(22)DOI:10.3390/jcm14227958. PMID:41302994. IF:2.900(Q1/2D).

01/11/2025 Response to Sonidegib in Advanced Basal Cell Carcinomas by Histological Subtype: A Real-World Cohort

Jiménez-Sánchez, A, Moreno-Arrones, OM, Béa-Ardebol, S, Mayo-Martínez, F, Pérez-Pastor, G, Torres-Navarro, I, Bonfill-Orti, M, Ruiz-Salas, V, Masferrer, E, Martos-Cabrera, L, Deza, G, Cabrera, RFDM, Feal, C, Turrión-Merino, L, Toll, A, Pérez, CA, Estrada, RB, Yébenes, M, Galiano-Mejías, S, Jiménez-Gallo, D, Ferrandiz-Pulido, C, Florez, A, Hernández-Hernández, N, Rios-Buceta, L, Sanmartín, O, Blanco, CC, Jaka, A, Just-Sarobé, M, Conde-Taboada, A, Arenal, MM, Vargas-Laguna, E, León, IA, Leal, L, Montalvo, SM, Polo, I, Hernández-Marín, B, Soria, A, Delgado-Jiménez, Y, Rodriguez-Jiménez, P. Response to Sonidegib in Advanced Basal Cell Carcinomas by Histological Subtype: A Real-World Cohort. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2025; 64(11)DOI:10.1111/ijd.17896. PMID:40468572. IF:3.200(Q1/3D).

01/11/2025 Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response

Mansilla-Polo, M, García-Moronta, C, Fernández-Crehuet, P, Garbayo-Salmons, P, Pons-Benavent, M, Aguilar-González, L, Jiménez-Gallo, D, Alcalá-García, R, Martín-Ezquerra, G, Martorell, A, Mahiques-Santos, L, Alfageme-Roldán, F, Escutia-Muñoz, B, Sahuquillo-Torralba, A, Fayos-Gregori, R, Soto-Moreno, A, Sánchez-Gutiérrez, I, Botella-Estrada, R, Vilarrasa, E, Molina-Leyva, A. Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response. Dermatology and Therapy. 2025; 15(11)DOI:10.1007/s13555-025-01521-z. PMID:40866757. IF:4.200(Q1/1D).

01/11/2025 Systemic treatment of immune checkpoint inhibitor-induced psoriasis: Inference-based guidance

Papp, KA, Puig, L, Beecker, J, Chandran, V, Claveau, J, Cortes, J, Dutz, J, Hornick, NI, Juergens, RA, Melosky, B, Patel, AB, Sauder, MB, Sehdev, S, Sibaud, V, Snow, SL. Systemic treatment of immune checkpoint inhibitor-induced psoriasis: Inference-based guidance. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39(11)DOI:10.1111/jdv.20809. PMID:40685883. IF:8.000(Q1/1D).

01/11/2025 [Translated article] Methotrexate-Induced Gouty Arthritis in Psoriatic Patient

Carmona-Rocha, E, Torné, CD, Alonso, AML, Puig, L. [Translated article] Methotrexate-Induced Gouty Arthritis in Psoriatic Patient. Actas Dermo-Sifiliograficas. 2025; 116(10)DOI:10.1016/j.ad.2025.10.010. PMID:41067613. IF:(Q/D).

01/11/2025 [Translated article] Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) Still be Part of the Baseline Series?

Fernández, CPH, Borrego, L, Arnau, AMG, Sánchez, TS, Carrillo, JMC, Ninet, VZ, Baldrich, ES, Miquel, FJM, Salvador, JFS, Guijarro, SC, Gilo, AS, García, PM, Triviño, FN, Romero, FT, Serna, MR, Ninot, GM, González, IR, de la Fuente, EG, Nieto, MAP, Guillén, PSP, Pérez, JS, Rodríguez, JJP, Ortega, MEG, Pérez, RG, Doval, IG, Descalzo, MAG. [Translated article] Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) Still be Part of the Baseline Series?. Actas Dermo-Sifiliograficas. 2025; 116(10)DOI:10.1016/j.ad.2025.10.016. PMID:41076186. IF:(Q/D).

30/10/2025 Predictors of response to omalizumab and relapse in chronic spontaneous Urticaria: a narrative review focusing on parameters available in routine clinical practice

Mateu-Arrom, L, Nogueira, XAV, Puig, L, Spertino, J. Predictors of response to omalizumab and relapse in chronic spontaneous Urticaria: a narrative review focusing on parameters available in routine clinical practice. Frontiers In Allergy. 2025; 6DOI:10.3389/falgy.2025.1688464. PMID:41246132. IF:(Q/D).

01/10/2025 Letter to the Editor Regarding: "Cardiovascular and Kidney Outcomes After Systemic Treatment for Plaque Psoriasis: A Systematic Review and Network Meta-Analysis"

Torres, T, Puig, L. Letter to the Editor Regarding: "Cardiovascular and Kidney Outcomes After Systemic Treatment for Plaque Psoriasis: A Systematic Review and Network Meta-Analysis". Dermatology and Therapy. 2025; 15(10)DOI:10.1007/s13555-025-01513-z. PMID:40779225. IF:4.200(Q1/1D).

01/10/2025 Comparative Effectiveness and Durability of Biologics Through 24 Months for Patients with Moderate-to-Severe Psoriasis: Results from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)

Pinter, A, Brnabic, A, Trovato, E, Puig, L, Carrascosa, JM, Boye, T, Megna, M, Sabatino, S, de la Torre, I, Maul, JT. Comparative Effectiveness and Durability of Biologics Through 24 Months for Patients with Moderate-to-Severe Psoriasis: Results from the International, Observational Psoriasis Study of Health Outcomes (PSoHO). Dermatology and Therapy. 2025; 15(10)DOI:10.1007/s13555-025-01494-z. PMID:40699538. IF:4.200(Q1/1D).

01/10/2025 'Knowing and Treating Kosaki/Penttinen syndrome' international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors

Bouhatous, YM, Bredrup, C, Maurer, A, Mirakovska, L, Foster, A, Kosaki, K, Jost, C, Demoulin, JB, Luu, M, Vabres, P, Kurtz, JE, Schaefer, E, Guimier, A, Cormier-Daire, V, Lim, D, Thompson, S, Olson, L, Kwon, HR, Aguirre-Rodriguez, C, Hernandez-Dorronsoro, U, Martinez-Soroa, I, Iznardo, H, Mascaro, JMJ, Baselga, E, Kalantari, S, Mussa, A, Gazzin, A, Carli, D, Svinvik, I, Mutlu-Albayrak, H, Bluefeather, S, Zarate, Y, Takenouchi, T, Naicker, T, Chateau, A, Gokhul, A, Dube-Pule, A, Haniffa, M, Peitee, WO, Nordgren, A, Carpentier, M, Binquet, C, Briffaut, AS, Bal, L, Pond, D, Rustad, CF, Bardou, M, Faivre, L. 'Knowing and Treating Kosaki/Penttinen syndrome' international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors. JOURNAL OF MEDICAL GENETICS. 2025; 62(10)DOI:10.1136/jmg-2024-110600. PMID:40707250. IF:3.700(Q2/3D).

01/10/2025 Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference on Sleep over 52 Weeks in Patients with Moderate-to-Severe Atopic Dermatitis in Two Phase 3 Trials

Yosipovitch, G, Lio, PA, Rosmarin, D, Legat, FJ, Serra-Baldrich, E, Carrascosa, JM, Bardolet, L, Crane, H, Casillas, M, Pierce, E, Zhong, JL, Elmaraghy, H, Ständer, S. Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference on Sleep over 52 Weeks in Patients with Moderate-to-Severe Atopic Dermatitis in Two Phase 3 Trials. DERMATOLOGY. 2025; 241(4)DOI:10.1159/000547142. PMID:40602386. IF:2.700(Q2/4D).

27/09/2025 Icotrokinra in psoriasis: IL-23 receptor antagonism via oral peptide with biologic-level efficacy

Puig, L. Icotrokinra in psoriasis: IL-23 receptor antagonism via oral peptide with biologic-level efficacy. LANCET. 2025; 406(10510)DOI:10.1016/S0140-6736(25)01675-7. PMID:40976247. IF:88.500(Q1/1D).

01/09/2025 Ten-Year Experience in the Joint Dermatology-Rheumatology Approach to Patients With Psoriatic Arthritis

Ferrer, AL, Macias, HC, Sanz, LP, Alonso, AL. Ten-Year Experience in the Joint Dermatology-Rheumatology Approach to Patients With Psoriatic Arthritis. Actas Dermo-Sifiliograficas. 2025; 116(8)DOI:10.1016/j.ad.2025.06.013. PMID:40570946. IF:(Q/D).

01/09/2025 Real-World Evidence for Ixekizumab in the Treatment of Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: Systematic Literature Review 2022-2023

Puig, L, Sewerin, P, Schuster, C, Ng, KJ, Papadimitropoulos, M, Gadagamma, S, Nuñez, M, Lampropoulou, A. Real-World Evidence for Ixekizumab in the Treatment of Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: Systematic Literature Review 2022-2023. ADVANCES IN THERAPY. 2025; 42(9)DOI:10.1007/s12325-025-03258-9. PMID:40676380. IF:4.000(Q1/3D).

01/09/2025 Patient Perspectives on the Impact of Living With Hidradenitis Suppurativa: Results From the Global 'HS Uncovered' Burden of Disease Survey

Kokolakis, G, Vilarrasa, E, Garg, A, Alarcon, I, Go, M, Newbold, G, Mamareli, A, Richardson, C, McGrath, BM, Guillem, P. Patient Perspectives on the Impact of Living With Hidradenitis Suppurativa: Results From the Global 'HS Uncovered' Burden of Disease Survey. Jeadv Clinical Practice. 2025; 4(4)DOI:10.1002/jvc2.70071. PMID:. IF:(Q/D).

01/09/2025 Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results

Papp, KA, Lebwohl, MG, Puig, L, Ohtsuki, M, Beissert, S, Gooderham, M, Amin, AZ, Wu, TS, Rubant, S, Bialik, B, Ashley, D, Soliman, AM, Chen, MM, Blauvelt, A. Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2025; 26(5)DOI:10.1007/s40257-025-00964-6. PMID:40728772. IF:8.800(Q1/1D).